Drugs - Real World Outcomes (2017) 4:175–182 DOI 10.1007/s40801-017-0112-y ORIGINAL RESEARCH ARTICLE Rare Cyclophosphamide-Induced Hemorrhagic Cystitis in a Chinese Population with Rheumatic Diseases 1 1 2 3 • • • • Liuqin Liang Donging Chen Xiaodong Wang Zheng Yang 1 1 1 • • Jun Zhou Zhongping Zhan Fan Lian Published online: 23 June 2017 The Author(s) 2017. This article is an open access publication Abstract hydration, and bladder irrigation. The other two were Objective The aim of this study was to investigate the unresponsive to the above treatment and ﬁnally had reso- prevalence, severity, risk factors, and treatment outcomes lution after cystectomy. The average resolution time of of cyclophosphamide (CYC)-induced hemorrhagic cystitis hematuria was 39.5 days (7–56 days). There were no (HC) in patients with rheumatic diseases. deaths in our cohort. Methods We collected the clinical data from 1284 con- Conclusion CYC-induced HC was rare and highly variable secutive patients admitted to The First Afﬁliated Hospital in Chinese patients with rheumatic diseases. Individualized of Sun Yat-Sen University who were treated with CYC treatment should be performed according to the severity of between 2006 and 2016, and then conducted a retrospective HC for each patient. More aggressive treatment strategies
Drugs - Real World Outcomes – Springer Journals
Published: Jun 23, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera